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Abstract
Nanomaterials are increasingly being used for commercial purposes. However, concerns about the 
potential risks of exposure to humans have been raised. We previously reported unusual 
pulmonary disease and death in a group of patients with occupational exposure to spray paint. 
However, the nanoparticle and chemical composition of the exposure was not fully described. The 
present study aimed to isolate and identify the nanoparticles observed in the patients’ biopsies and 
report the potential deleterious effects to human lungs using electron microscopy. Using electron 
microscopy and energy dispersive x-ray analysis, silica nanoparticles were identified and 
characterized mainly in macrophages, pulmonary microvessels, vascular endothelial cells, 
microlymphatic vessels, pleural effusions, and a few in alveolar epithelial cells and pulmonary 
interstitial tissue (with no microscale particles present). Notably, damage to alveolar epithelial 
cells, macrophages, vascular endothelial cells, and the blood–gas barrier was observed. Given the 
well-documented toxicity of microscale silica, it is possible that these silica nanoparticles may 
have contributed in part to the illness reported in these workers. Such a possibility supports the 
adoption of controls and prevention strategies to minimize inhalation of nanoparticles by workers, 
and it highlights the urgent need and the importance of the nanosafety study in humans.
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Nanotechnology has been regarded as a new technological revolution that touches almost 
every aspect of human life, making its presence felt in areas such as electronics, coatings, 
optical devices, energy, and medicine. It is estimated that the worldwide market for 
nanomaterials will grow to $3.1 trillion by 2015 (Lux report 2008). On the other hand, 
because of their widespread use, small size, large surface area, and metal contaminants, 
nanomaterials may exhibit unique bioactivity and interaction with cellular or subcellular 
structures. Therefore, concerns and fears have been expressed regarding potential risks of 
nanoparticles to the environment, health, and safety (Nel et al. 2006; Schmidt 2009). 
However, studies determining which physicochemical properties of nanomaterials result in 
toxicity have been scarce.
Previously, we reported findings (Song et al. 2009) regarding a group of patients who were 
exposed to polyacrylate spray paint in a poorly ventilated workplace for five to thirteen 
months. Nanoparticles were associated with this polyacrylate coating. Affected workers 
suffered mysterious clinical symptoms (pleural effusions, progressive pulmonary fibrosis, 
and pleural damage) and death. Nanoparticles were found in the patients’ pulmonary tissues, 
bronchoalveolar lavage fluid, and chest effusions, as well as in the raw materials used by 
these workers. It is inferred that these nanoparticles may be related to the patients’ disease, 
but the chemical composition of the nanoparticles remains unknown. For this reason and the 
fact that none of the nanoparticles was likely to induce the severe toxic effects reported in 
animal experiments, some researchers have argued that the disease may have been related to 
other factors such as gases, as the raw material examined by gas chromatograph–mass 
spectrometer contained many gases, including butanoic acid, butyl ester, acetic acid, 
toluene, acetic acid ethenyl ester, and 1-ethylene dioxide. Unfortunately, these patients 
exhibited none of the signs and symptoms related to these irritant or asphyxiant gases, such 
as coughing, eye irritation, dizziness/headaches, drowsiness, nausea, or vomiting. 
Additionally, pulmonary clinicopathology showed a progressive feature even in the absence 
of continued exposure, a major indication that lessened the probability that the observed 
symptoms were caused by a gas or gases.
In the present study, examination of the patients’ biopsies and chest fluids by transmission 
electron microscopy (TEM) and energy dispersive x-ray analysis (EDX) permitted the 
isolation and identification of nanomaterials in biopsies. Also, we report the potential 
deleterious effects of nanomaterials on human lungs, which have not been previously fully 
described and reported.
Methods
Transmission Electron Microscopy of Pulmonary Biopsies and Chest Membranes and EDX 
of Nanoparticles
The formaldehyde-fixed and paraffin-embedded pulmonary tissues and/or pleural 
membranes, obtained from affected workers in a spray paint facility upon admission to 
Beijing Chaoyang Hospital, Beijing, China, between January 2007 and April 2008, were 
used for TEM examination and EDX analysis. Tissue fragments of 1 mm3 (1 mm × 1 mm × 
1 mm) were cut with a sharp razor blade from distinct, randomly chosen areas of the paraffin 
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block and reprocessed as follows. Xylene dewaxing was performed in a 50°C oven for two 
hours to remove paraffin, and tissues were lightly rehydrated with graded acetone (at 40°C 
in 100% acetone for one hour; and at room temperature in 90%, 70%, 50%, and 30% 
acetone for fifteen minutes, respectively). Specimens of the samples were rinsed overnight 
in 0.1 M phosphate buffer (350 mOsm, pH 7.4); postfixed for two hours in osmium tetroxide 
(1% osmium tetroxide in 0.125 M sodium cacodylate buffer, 400 mOsm, pH 7.4); rinsed 
again in 0.1 M phosphate buffer (three × ten minutes); passed through stepwise dehydration 
in increasing concentrations of ethanol (50%, 70%, 90%, and 100%); rinsed with 100% 
propylene oxide (two × ten minutes); and embedded in Araldite (at 37°C for two hours, 
45°C for twelve hours, and 60°C for twenty-four hours). Then they were cut into ultrathin 
sections (500–800 Å) and stained with uranyl acetate and lead citrate. The samples were 
then examined at an accelerating voltage of 60 or 200 kV using different TEMs and also 
analyzed using EDXs (JEOL JEM-2010F, EDX: INCA-IET200 B5~U92; TECNAI G2 20 S-
TWIN, EDX: GENESIS 2000) by different laboratories. Also, changes in cell morphology 
of lung tissue samples were observed and assessed. The specimen from a lung tumor patient 
was used as a control in TEM and EDX analysis and was processed as described above.
Analysis of Patients’ Pleural Fluids
Nanoparticle Morphology, Size, and Chemical Composition—Pleural effusions 
were obtained from four of seven patients upon admission to our hospital in April 2008 and 
were stored at −20°C. Samples were randomly used and melted under normal room 
conditions. When the chest fluid samples were centrifuged at 123.6 × g, stained with uranyl 
acetate, and air dried, round nanoparticles were observed to be wrapped in a fibrous 
structure (Song et al. 2009). Thus, at this time, chest effusions were then centrifuged at 
8,500 × g at room temperature for ten minutes, and a drop of the resulting supernatant liquid 
was overlaid onto 400-mesh carbon-coated copper grids (not stained by uranyl acetate), air-
dried, and observed using TEM by different laboratories. These preparations were also 
analyzed by EDX single-spot analysis to illuminate particle morphologies and to identify the 
particle composition. In addition, qualitative analysis was also performed.
Analysis by Inductively Coupled Plasma Mass Spectrometry (DRC-II, Perkin-
Elmer) or Atomic Absorption Flame Spectrophotometry (AA-6800/F, 
Shimadzu) for Determining Ca, Mg, Cu, Fe, and Zn Concentrations—Chest fluid 
from three of seven patients was analyzed for Si, Ca, Mg, Cu, Fe, and Zn, since metallic 
compounds are usually used as additives in coatings production. Chest fluid from patients 
with lymphoma, lung cancer, or malignant melanoma in our tumor department was used as 
controls. Certified standard samples of Si, Ca, Mg, Cu, Fe, and Zn were obtained from the 
National Research Center for Certified Reference Materials, China.
Histological Changes in Patients’ Lungs
All examinations were approved by our hospital’s ethics commission, and informed consent 
was obtained before all the examinations and procedures. The biosamples from seven 
patients included tunica mucosa bronchiorum, pulmonary tissues, and pleural membranes. 
All of these samples were obtained from patients between January 2007 and April 2008, 
when the patients were admitted to our hospital and underwent a variety of procedures, 
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including bronchoscopic examinations with bronchoalveolar lavage and transbronchial lung 
biopsy, internal thoracoscopic examinations with lung biopsy, and video-assisted thoracic 
surgery with wedge resection. Pathological changes were carefully observed and revised 
under light microscopy in different laboratories.
Results
Nanoparticles Observed and Identified in Lung Tissue and Lung Injury under TEM
Early Stage Location of Nanoparticles in Exposed Lungs—In the early stages 
(within three months of disease onset), nanoparticles 20–21 nm in diameter were observed 
and found to be located in the cytoplasm (Figure 1A), nuclei and organelles of macrophages, 
pulmonary microvessels (Figures 1B and 1C), pulmonary vascular endothelial cells, and 
microlymphatic vessels. In contrast, only a few were observed in alveolar epithelial cells and 
interstitial tissues. When analyzed by EDX, all of these nanoparticles contained Si, O, P, and 
S (Figure 1D), and, occasionally, K and Fe were detected. On the other hand, using TEM, 
the specimen from the control tumor patient was also observed to contain structures 
resembling nanoparticles (Figure 1E). However, no Si was detected by EDX analysis, but O, 
S, Cl, and elements from stains were detected (Figure 1F), indicating that these structures 
were just stains or other cellular components such as glucogen. From comparison with 
control peaks (peaks of C and Cu oriented on carbon Cu-grids), it was concluded that these 
were silica nanoparticles. These particles consisted of 20–21 nm primary nanoparticles and 
agglomerates of these particles, indicating they were engineered nanomaterials. Further 
qualitative analysis showed that the O/Si ratios at the k atomic orbital varied from 4.43:1 to 
18.0:1 by weight-%, and the O relative contents were more than in the O/Si ratio of 1.2–
1.6:1, which may have been because there were hydroxyls or H2O on the silica nanoparticle 
surfaces, or because of the contribution of O in alveolar cells. In general, particles larger 
than 100 nm, or other kinds of particles such as nanosilicates, were not observed in patients’ 
lung tissues.
Early Stage Lung Damage in Affected Workers—Pulmonary tissue and cells were 
found to be deteriorated. Early in the disease process, TEM examination of lung tissue 
demonstrated hyperplasia and degeneration of type II pneumocytes with short microvilli 
thinning and loss, and thickening of the basement membrane of type I alveolar epithelial 
cells, as well as pulmonary interstitial edema. Also, vascular endothelial cell damage was 
noted with the swelling and vacuolization of cell organelles and the thickening of the 
basement membrane. The blood–gas barrier appeared fuzzy and was much thicker than 
normal (>0.5 μm), and its structure was difficult to distinguish (Figure 1B).
Late-Stage Location of Nanoparticles in Exposed Lungs—In the late disease stage 
(eighteen months, just prior to death), few nanoparticles were observed in pulmonary cells 
and interstitial tissue, as well a few in macrophages. However, some fibrous nanostructured 
bodies ~70 nm in length were observed in the nuclei and cytoplasm of alveolar epithelial 
cells, where they formed tangled agglomerates (Figure 2A) or crossed the nuclear membrane 
of alveolar epithelial cells. Using EDX single spot analysis, these fibrous nanostructured 
bodies were found to contain Fe, Ca, and Mg, but not Si. Also, microscale particles were not 
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observed in the patient’s lung tissues, which suggested that microscale particles may be less 
likely to be involved in the lung injury process.
Late-Stage Lung Damage in Affected Workers—In late-stage disease, damage to 
pulmonary tissue was more prominent than that in the early stage. Hyperplasia and vacuolar 
degeneration of type II pneumocytes with thinning and loss of surface microvilli (Figure 
2B), as well as thickening and blurring of type I epithelial basement membranes and 
vascular endothelial cell basement membranes, was observed. Also, the blood–gas barrier 
structure appeared fuzzy and difficult to distinguish. Red blood cells were observed in 
alveolar spaces, which is indicative of potential alveolar hemorrhage and edema. Pulmonary 
fibrosis with fibroblast proliferation and fibrinous necrosis was also noted, and under TEM, 
pleural membranes showed edema, fibrosis, looseness, and blurring of cell structures. These 
observations were consistent with the present diagnosis of pulmonary pathology. Also, a 
great number of macrophages were observed as aggregations in the late stage as in the early 
disease process, indicating that macrophages may play some roles in the development of the 
disease; these particle-laden aggregations were ever seen in pulmonary illness caused by 
microscale silica (Kim et al. 2001).
Morphology and Size of Chest Fluid Nanoparticles
Particles with different sizes varying from ~20 nm to ~2 nm in diameter were observed 
(Figure 3A) in patients’ pleural effusions, although homogeneous nanoparticles were noted 
when pleural effusions were centrifuged at 123.6 × g (Song et al. 2009). When analyzed by 
EDX, the particles contained Si, O, C, and Cu (Figure 3B). By comparison with a blank 
(Figure 3C), these particles were identified as silica nanoparticles (where C and Cu peaks 
originated from the carbon-coated copper grids). Further qualitative analysis showed that the 
O/Si ratio varied from 3.98:1 to 7.75:1 by atomic mass-% and from 2.28:1 to 4.34:1 by 
weight-%, which suggests the presence of hydroxyls or H2O on the silica nanoparticle 
surfaces. However, the sizes of the silica nanoparticles in the pleural effusions were a little 
smaller than in the pulmonary tissue, possibly because of a size-dependent translocation of 
particles from the lungs.
Importantly, in one patient’s pleural effusions, layered crystals and cleavage fragments, 
varying in size from micro- to nanoscale, were noted (Figure 3D). Some crystals contained 
Si, Ca, Mg, S, Cl, and O, indicating the presence of a magnesium silicate such as talc, and 
some contained more complex mixtures of Si, Ca, Mg, Al, P, S, Cl, and O (Figure 3E). 
Additionally, nanosilica particles, as well as nanosilicate particles containing Si, Ca, Mg, Al, 
K, Na, Ba, P, S, Cl, and O, were confirmed by EDX analysis and noted to be scattered 
around the microsilicates. Si was detected in every particle observed in the pleural effusions, 
but with varying relative contents.
In summary, we conducted EDX analysis of four patients’ (out of seven) pleural effusions 
and/or their lung biopsies in different laboratories. These four patients included the nineteen-
year-old and the twenty-nine-year-old female patients who died of pulmonary failure, and 
the eighteen-year-old and the forty-seven-year-old female patients who were severely 
disabled (EDX analysis was not conducted in the other female patients because of a lack of 
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biosamples). We found that silica nanoparticles existed in all four patients, either in 
pulmonary biopsies (early stage) or pleural effusions. Occasionally, nano- and microscale 
silicates were found in chest fluids, but not in any of the four patients’ lung tissues. The 
TEM images presented here indicate that these silica nanoparticles identified—the highly 
spherical and uniform nanoscale particles—are most likely amorphous in nature, as is the 
case for most known engineered forms of spherical silica in the nanoscale size range.
Inductively Coupled Plasma Mass Spectrometry and Atomic Absorption Flame 
Spectrophotometry of Pleural Effusions
Concentrations of Ca, Mg, Cu, Fe, and Zn were analyzed in chest fluids, showing that the 
concentrations of these elements were lower in the patients’ pleural effusions than in the 
tumor patient controls (effusion, control’, n = 3): Cu, 0.282 ± 0.216 mg/L; Cu’, 0.721 ± 
0.091 mg/L; Mg, 8.190 ± 4.609 mg/L; Mg’, 17.623 ± 1.753 mg/L; Ca, 17.423 ± 10.782 
mg/L; Ca’, 81.694 ± 9.779 mg/L; Fe, 0.310 ± 0.208 mg/L; Fe’, 3.888 ± 4.813 mg/L; Zn, 
0.125 ± 0.128 mg/L; and Zn’, 0.363 ± 0.216 mg/L. However, the concentration of Si in 
patients’ pleural effusions was 4.844 ± 0.431 mg/L, about two times of that in tumor 
patients’ chest fluids (2.530 ± 0.206 mg/L).
Histological Changes in Patients’ Lungs
In the early disease stage, pathological examination using light microscopy showed the 
effusion of inflammatory cells in tunica mucosa bronchiorum; aggregations of macrophages 
and inflammatory cells; proteinaceous effusions in the alveolar space; swollen and widened 
alveolar septa with scattered neutrophil leukocytes; and pulmonary fibrosis (Figure 4A). 
Pathological study of pleura exhibited fibrinous and inflammatory cells, foreign-body 
granulomas, and hemorrhage. The results of all patients were consistent but nonspecific.
In the late stage, damage to pulmonary tissue was similar to but more prominent than that in 
the early stage. Pulmonary alveoli were partly emphysematous, with aggregations of 
macrophages and type II alveolar epithelial cell proliferations, and the alveolar septum was 
widened with blood vessel dilatation and congestion (Figure 4B). Pathological study on 
pleura showed fibrous thickening and swelling of the pleural membrane, fibroblast 
proliferation, lymphocyte aggregation, and nodulus lymphaticus formation.
Discussion
From the above observations and analyses, silica nanoparticles were identified in patients’ 
lungs and their pleural effusions. Distribution and translocation of these nanoparticles were 
determined mainly in pulmonary microvessels, vascular endothelial cells, macrophages, and 
microlymphatic vessels of patients’ lungs. A few particles were found in alveolar epithelial 
cells and pulmonary interstitial tissue (with no microscale particles present). In pleural 
effusions, the particles appeared slightly smaller in size than those in lung tissues, and 
micro- and nanosilicates were noted in one patient’s chest effusion and contained thirteen to 
fifteen different elements and widely varying O/Si ratios. Notably, damage to vascular 
endothelial cells, alveolar epithelial cells, and macrophages, as well as the blood–gas barrier, 
was observed. Additionally, the concentration of Si in patients’ pleural effusions was about 
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two times that in tumor patients’ chest fluids. These data provided important information to 
understand the unique nanoparticle-induced lung disease process, which seems to be 
dependent on where the nanoparticles are located and whether they are persistent in the lung.
The toxicity of silica has been widely studied because of its ubiquity and wide use in many 
industries. Exposure to silica (mainly crystalline silica) can result in or contribute to a series 
of severe respiratory diseases, including silicosis, interstitial fibrosis, industrial bronchitis, 
small airway disease, emphysema, and vascular diseases, as well as immunologic reactions 
(Ding et al. 2002; Hnizdo and Vallyathan, 2003; Merget et al. 2002; Thibodeau et al. 2004). 
Even though amorphous silica appears less toxic than the crystalline form, toxicological 
studies of amorphous silica nanoparticles have shown that amorphous silica increases 
reactive oxygen species concentrations, reduces glutathione levels, and induces pro-
inflammatory, inflammatory, and oxidative stress responses both in vivo and in vitro 
(Kaewamatawong et al. 2006; Park and Park 2009; Slowing et al. 2009; Wang et al. 2009; 
Ye et al. 2010). One of the notable bio-effects of amorphous silica nanoparticles is that they 
can enter cell nuclei (Chen and von Mikecz 2005), including human lung cells (Song et al. 
2009), where they reduce aberrant clusters of topoisomerase I and protein aggregates in the 
nucleoplasm. In vitro studies also show that amorphous silica nanoparticles disturb 
mitochondrial function and lower cell survival by decreasing cell survival signaling in 
human neural cells (Lai et al. 2010), and they exert cytotoxicities by altering protein 
expression in HaCaT cells (Yang et al. 2010). A recent study found that amorphous silica 
nanoparticles (70 nm) localize in the cytoplasm, nucleus, and mitochondria in mouse liver, 
and they induce mutagenic activity in vitro (Nabeshi et al. 2011). Moreover, amorphous 
nanosilica has been shown to accumulate in the lung, liver, kidney, gut, bone marrow, and 
brain in animal experiments and cause multiorgan damage (Kaewamatawong et al. 2006; 
Nishimori et al. 2009a; Nishimori et al. 2009b; Oberdörster et al. 2005).
Our present findings that silica nanoparticles localized in cytoplasm, subcellular organelles, 
and cell nuclei, entered pulmonary microvessels, and thereby reached extrapulmonary 
multiorgans through systemic circulation raise important concerns: (1) Did these silica 
nanoparticles in the nuclei potentially bind to the DNA phosphate backbone, influence 
nuclear integrity, and trigger genotoxicity by physical interaction, forming intranuclear 
protein aggregates, and regulating redox-sensitive transcription factors and DNA-damage 
responsive signaling, as seen in animal-based nanotoxicological studies (Chen and von 
Mikecz 2005; Nabeshi et al. 2011; Singh et al. 2009)? (2) Did these silica nanoparticles in 
cytoplasm exert cytotoxicity by increasing reactive oxygen species and by inducing pro-
inflammatory, inflammatory, and oxidative stress responses, as seen both in vivo and in 
vitro (Kaewamatawong et al. 2006; Park and Park 2009; Slowing et al. 2009; Ye et al. 
2010)? (3) Did these silica nanoparticles enter extrapulmonary organs through systemic 
circulation and cause multiorgan damage, as seen in animal experiments (Kaewamatawong 
et al. 2006; Nishimori et al. 2009a; Nishimori et al. 2009b; Oberdörster et al. 2005)? All of 
the above concerns highlight the urgent need and the importance of the safe usage and risk 
assessment of nanomaterials, and of developing prevention strategies.
Given the well-documented toxicity of microscale silica in humans and findings of 
amorphous silica nanoparticles in animals (Kaewamatawong et al. 2006; Nishimori et al. 
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2009a; Nishimori et al. 2009b; Oberdörster et al. 2005), it is possible that these silica 
nanoparticles may have contributed in part to these patients’ disease, whether they exerted 
toxicities directly or acted as carriers, although further evidence is needed to make a direct 
causal linkage between the silica nanoparticles in patients’ lungs and their respiratory 
problems and the death of two workers as they worked under complex conditions and 
inhaled a cocktail of toxic materials. To date, little information regarding the clinical toxicity 
of nanosilica has been published. As nano- and microscale silica are found to induce 
cytokine release and apoptosis in macrophages in in vitro and in vivo studies (Ding et al. 
2002; Park and Park 2009; Thibodeau et al. 2004; Wang et al. 2009; Ye et al. 2010), taken 
together with our findings of nanosilica in macrophages undergoing apoptosis (Song et al. 
2009), it is suggested here that apoptosis is one mechanism of nanosilica-related 
macrophage damage in humans. Also, in these patients, the clinical manifestation of 
nonspecific inflammation detected in CT scans and pathological examinations may have 
been partly caused by silica nanoparticle accumulation and the resulting induced 
inflammatory response.
In pulmonary illness caused by microscale silica, macrophages have been observed as 
particle-laden aggregations (Kim et al. 2001), a reaction that is typically seen with inert 
dusts. Similar aggregations of macrophages were observed in our patients in the early stage 
of disease, with numerous silica nanoparticles aggregating in the cytoplasm, mitochondria, 
lysosomes, and karyoplasm of macrophages. The retention half-life of solid particles in the 
alveolar region, mediated by alveolar macrophages through phagocytosis of deposited 
particles, is about 70 days in rats and up to 700 days in humans (Oberdörster et al. 2005). In 
our patients, the retention half-life of silica nanoparticles appeared to be about 100 days, as 
about eighteen months later following the final raw material exposure, few nanoparticles 
were observed in pulmonary cells and interstitial tissue, as well a few in macrophages, 
which is consistent with previous literature reporting that the retention half-life of 
nanoparticles by the mechanical alveolar macrophage-mediated clearance is about 70 days 
(Hoet et al. 2004).
The reported patients had been exposed to polyacrylate coatings, which usually have several 
components of binders, pigments, solvents, fillers, and additives (Liu 2008). Fillers and 
additives are generally composed of natural or synthetic minerals, such as silicon dioxide, 
barium sulfate, calcium carbonate, silicates (talc, mica, or kaolinite), or a complex mixture 
of the above materials, to produce special and improved functions, such as water resistance, 
transparency, and flame retardation (Liu 2008; Wang et al. 2006; Zhou et al. 2002). Because 
of their small size, large specific surface area, and alkyl groups in different bonding states, 
silica nanoparticles in coatings can markedly improve the suspension stability, 
weatherability, tensile strength, and resistance of a coating to washing, infrared irradiation, 
abrasion, and heat while maintaining a clear surface (Wang et al. 2006; Zhou et al. 2002). In 
contrast, microsilica can increase only the hardness and abrasion resistance (Zhou et al. 
2002). Similarly, layered silicates, another very popular coating ingredient, play an 
important role as adsorbents, catalysts, and ionic exchangers in the production of 
nanocoatings and can greatly increase thermal stability and act as fire retardants in the form 
of nanocomposites (Alexandre and Dubois 2000; Schmidt and Giannelis 2010).
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Given the benefits of nanosilica and/or nanosilicates, they are sometimes used concurrently 
in varying ratios to each other in the production of nanocomposite coatings (Liu 2008) to 
obtain specific coating characteristics. Thus, a possible rough sketch can be made of the 
coatings used at these patients’ workplace: filters and additives of nanosilica and/or micro- 
and nanosilicates, a film-forming polyacrylate agent, and various solvents, including 
butanoic acid, acetic acid, and toluene. Furthermore, using inductively coupled plasma 
atomic emission spectrometry examination (Ma 2009), the powder in the raw materials used 
in the workplace (the spray painting) was found to contain these elements in the following 
percentages: Si, 0.016; Ca, 0.20; Mg, 0.051; K, 0.015; Na, 0.82; Ba, 0.069; P, 0.048; Cu, 
0.0090; Fe, 0.098; and Zn, 0.0085. These results are almost identical to our findings of silica 
nanoparticles and micro- and nanosilicates in patients’ pleural effusions that contain Si, Ca, 
Mg, K, Na, Ba, Al, P, S, Cl, and O. When coatings were sprayed, heated, and dried in the 
workplace, these nanosilica and/or nanosilicates in the coatings were possibly present in the 
air as floccule; entered the pulmonary alveoli, blood, and lymph systems; and finally 
reached extrapulmonary organs of the patients, as observed in animal experiments 
(Nishimori et al. 2009a; Oberdörster et al. 2005; Oberdörster 2010; Singh et al. 2009). Thus 
they potentially contributed in part to the multiorgan injuries seen in our patients (Song et al. 
2009).
Another important material found in one patient was micro- and nanosilicates. It appears a 
little puzzling that the micro- and nanosilicates were noted in one patient’s chest effusion, 
since only nanoparticles but not microscale particles were observed in the raw materials 
used in the workplace. Also, what were the fibrous nanostructured bodies in alveolar 
epithelial cells, and how did they get there? The reason may be the raw materials—a poor-
quality product (a “three-no” product: no trademark, origin, or material safety data sheet, 
chosen to decrease expenses)—used in the workers’ polystyrene processing surroundings. 
Another reason is that, in reality, workers are usually exposed to very complex conditions in 
which nanomaterials with different sizes, shapes, and chemical composition may be present 
and there is also the possible presence of microscale materials and some gases, which could 
potentially contribute to causing severe damage.
The sizes of silica nanoparticles in pleural effusions were not identical to those in alveolar 
tissue, but a little smaller, possibly a result of the size-selective differences in particle 
immobilization in lungs. Typically, the smaller the nanoparticles, the deeper they can travel 
into the lung, as reviewed in several articles (Borm et al. 2006; Hoet et al. 2004; Oberdörster 
et al. 2005). This particle size–dependent organ distribution has been confirmed in 
properties of iridium-192–radiolabeled nanoparticles (Semmler-Behnke et al. 2007) and 
gold nanoparticles (Sadauskas et al. 2009). Another reason is probably the chest fluid 
sampling, as homogeneous nanoparticles were noted when pleural effusions were 
centrifuged at 123.6 × g (Song et al. 2009).
There are still many outstanding questions here. For example, what is the possible surface 
contamination of silica nanoparticles? In proper perspective, however, these questions are 
not as important or urgent as questions regarding how to prevent the potential risks of these 
nanomaterials to workers and the environment.
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Our present study shows that silica nanoparticles can arrive at workers’ lungs, chest 
effusions, and pulmonary circulation, and they may have contributed in part to the workers’ 
illness and death, highlighting the urgent need for safety protocols that protect workers. 
Protocols or solutions may include regulations for occupational health and safety in 
nanofield work or research; workplace exposure assessment, monitoring, and controls; 
medical prescreening and surveillance; establishing industrial hygiene guidelines; and 
effective personal protective equipment or application of appropriate safeguards. In addition, 
given the severity of the disease as seen in our patients, and the great difficulties in diagnosis 
and treatment, it is a new challenge for our clinical doctors in terms of how to prevent, 
diagnose, and treat the disease or injury. Thus far, no medical laboratories in China are 
equipped with TEM and analytic systems such as EDX, x-ray diffraction, or x-ray 
photoelectron spectrometry, and the few top materials science and engineering institutes, 
which are well equipped, have staff that usually lack the proper biomedical knowledge and 
maintain TEM configurations unsuitable for biological samples. Most importantly, some 
patients exposed or suspected to have been exposed to nanomaterials are found with unusual 
clinical manifestations, making it very difficult to determine a causal relation between their 
nanomaterials exposure and their disorders.
In conclusion, our findings of nanosilica in patients’ biopsies and pleural effusions, together 
with our previous report (Song et al. 2009), present a clue that these silica nanoparticles may 
have contributed in part to the illness reported in these workers. Our findings highlight the 
urgent need and the importance of the nanosafety study, as well as the urgent need for safety 
protocols that protect workers and the environment. Our data in humans may provide useful 
information for intensely increased nanotoxicology research that would mimic nanomaterial 
exposure using animals or in vitro models to determine mechanisms. Nanomaterials offer 
great benefits as well as potential risks, which raises the question of how to enjoy their 
benefits while minimizing related potential hazards to humans as well as the environment. 
Answering these questions is an urgent and difficult global-level task.
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Figure 1. 
Transmission electron microscopy images of silica nanoparticles obtained from lung tissues 
of a nineteen-year-old female worker who was severely disabled. Nanoparticles 20–21 nm in 
diameter scattered in cytoplasm of a macrophage (A, scale bar = 200 nm), and a pulmonary 
microvessel (B, scale bar = 500 nm; and C, scale bar = 100 nm). Energy dispersive x-ray 
analysis (TECNAI G2 20 S-TWIN, EDX: GENESIS 2000) revealed they were silica 
nanoparticles (D), peaks of C and Cu oriented on carbon Cu-grids, and Pb from stains. 
Structures resembling nanoparticles were also observed in the specimen from the control 
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tumor patient (E, scale bar = 150 nm). No Si was detected, but there were stains (F) (JEOL 
JEM-2010F, EDX: INCA-IET200 B5~U92).
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Figure 2. 
Transmission electron microscopy images of fibrous nanostructured bodies and pulmonary 
damage in another nineteen-year-old female worker who died eighteen months after 
symptom onset. Fibrous nanostructured bodies ~70 nm in length were observed in the nuclei 
of an alveolar epithelial cell, where the nanostructure is in tangled form (A, scale bar = 30 
nm). B (scale bar = 2 μm) shows a fraction of a red blood cell in alveolar spaces, 
hyperplasia, and vacuolar degeneration of type II pneumocytes with thinning and loss of 
surface microvilli.
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Figure 3. 
Transmission electron microscopy images of nanomaterials obtained from chest fluid in a 
twenty-nine-year-old female worker who died twenty-one months after symptom onset. 
Nanoparticles varying from ~20 nm to ~2 nm in diameter were observed (A, scale bar = 10 
nm). Energy dispersive x-ray analysis (TECNAI G2 20 S-TWIN, EDX: GENESIS 2000) 
revealed that they were silica nanoparticles (B, C). Layered crystals with their cleavage 
fragments were noted, varying from nano- to microscale in size (D, scale bar = 220 nm) and 
containing the more complex elements of Si, Ca, Mg, Al, Cr, P, S, Cl, and O (E).
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Figure 4. 
Histological changes in patients’ lungs. In the early stage, aggregation of macrophages in the 
alveolar space, swollen and widened alveolar septa, and pulmonary fibrosis were observed 
(A, hematoxylin and eosin stain, 100×). In the later disease process, pulmonary alveoli were 
partly emphysematous with aggregations of macrophages and proliferations of type II 
alveolar epithelial cells, and the alveolar septum was widened with blood vessel dilatation 
and congestion (B, hematoxylin and eosin, 100×).
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